09/03/2014 - 12:54pm

PharmaSmart on Wednesday announced the debut of its next generation biometric kiosk, the Model PS2000 (D)estination, which recently completed a pilot inside Mariano’s, a grocer with 26 stores located in the Chicagoland Metro area. 

09/03/2014 - 9:30am

Teva Pharmaceutical on Wednesday announced that a positive judgment has been given by the U.K. High Court in support of Teva's case against AstraZeneca relating to the validity of EP 1,085,877 covering the SMART (Single inhaler Maintenance And Reliever Therapy) indication for AstraZeneca's fixed dose formoterol/budesonide combination product, Symbicort.

09/03/2014 - 6:36am

The Department of Health and Human Services last week published a final rule that allows healthcare providers more flexibility in how they use certified electronic health record technology to meet meaningful use for an EHR Incentive Program reporting period for 2014. 

 

09/03/2014 - 6:21am

The National Institutes of Health has issued a final NIH Genomic Data Sharing policy to promote data sharing as a way to speed the translation of data into knowledge, products and procedures that improve health while protecting the privacy of research participants. 

09/02/2014 - 2:52pm

ExceleraRx, a national specialty pharmacy network, last week named James Fox as its president and CEO, effective Sept. 1.

09/02/2014 - 11:21am

Acura Pharmaceuticals last week announced that it has been awarded a $300,000 grant by the National Institute On Drug Abuse of the National Institutes of Health to fund Phase I development of Acura's new, early stage Limitx abuse deterrent technology.

09/02/2014 - 11:15am

Among patients with hypertension at high risk of cardiovascular disease, a program where patients measured their blood pressure and adjusted their antihypertensive medication accordingly resulted in lower systolic blood pressure at 12 months compared with patients who received usual care, according to a study in the Aug. 27 issue of JAMA.

09/02/2014 - 10:57am

The asthma treatment market value will grow from approximately $15.9 billion in 2013 across eight major countries — the United States, United Kingdom, France, Germany, Spain, Italy, Japan and Australia — to $23.1 billion by 2023, according to research and consulting firm GlobalData.

09/02/2014 - 10:09am

Sandoz last week announced the U.S. market introduction of decitabine for injection, a generic version of Eisai’s Dacogen.